Reviewed profile

food and beverage brand · public preview

Ferrinject

Retail brand

Public category
Retail brand
Brand tier
mainstream brand
Headquarters
Switzerland
Report a changeLog in for full recordLast reviewed 29 May 2026 · public preview data

Overview

What Ferrinject covers.

Ferinject (ferric carboxymaltose) is an intravenous iron replacement therapy indicated for the treatment of iron deficiency anemia in adult and pediatric patients, as well as iron deficiency in adult patients with heart failure. The product is designed for use when oral iron preparations are ineffective or not tolerated. It is marketed by CSL Vifor, a pharmaceutical company specializing in iron deficiency and nephrology treatments.

  • Positioned as a mainstream brand.
  • Headquartered in Switzerland.

FAQ

Questions this page answers.

What does Ferrinject do?

Ferrinject is a food and beverage brand based in Switzerland, tracked in Talio's food and beverage intelligence platform.

Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

Own this company?

Get found by buyers — and the AI that recommends suppliers.

Claim this profile to appear in buyer searches, add your products and certifications, correct outdated details, and stay eligible when Talio's AI recommends suppliers.

Claiming grants reviewed submission rights only — not direct editing, suppression, or ownership of Talio-derived intelligence. Verification required.

Public preview data only · proprietary metrics remain in authenticated Talio.